Soleno Therapeutics (SLNO) EBT Margin Growth (1y) (2016 - 2017)

Soleno Therapeutics (SLNO) EBT Margin Growth (1y) (2016 - 2017) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (1y) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -153.00
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn -571.00
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 452.00
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 1,076.00
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -9,422.00
7 Royalty Pharma 33.72 Bn 35.84 Bn - -392.00
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 1,911.00
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 29,565.00
10 Soleno Therapeutics 2.74 Bn 2.49 Bn 93.41 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2017 -18.18 Mn
Mar 31, 2017 43,596.00
Dec 31, 2016 -142,851.00
Sep 30, 2016 69,049.00
Jun 30, 2016 -11.16 Mn
Mar 31, 2016 1.01 Mn